Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

St. Jude Medical, Inc. STJ NYSE

NYSE • Healthcare • Medical - Equipment & Services • USD

SharesGrow Score
65/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

St. Jude Medical, Inc. (STJ) is a Medical - Equipment & Services company in the Healthcare sector, currently trading at $80.82. It has a SharesGrow Score of 63/100, indicating a above average investment profile with 3 out of 7 criteria passed.

Financials: revenue is $5.5B, +0.2%/yr average growth. Net income is $880M, growing at +7.5%/yr. Net profit margin is 15.9% (healthy). Gross margin is 68.5% (-3.6 pp trend).

Balance sheet: total debt is $6.4B against $4.0B equity (Debt-to-Equity (D/E) ratio 1.58, leveraged). Current ratio is 1.32 (adequate). Debt-to-assets is 48.9%. Total assets: $13.1B.

SharesGrow 7-Criteria breakdown: Value 60/100 (Pass), Growth 55/100 (Partial), Past 100/100 (Pass), Health 50/100 (Partial), Moat 53/100 (Partial), Future ?/100 (Fail), Income 70/100 (Pass).

STJ SharesGrow Score Overview

65/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 60/100
Valuation — P/E, PEG, Forward PEG
GROWTH 55/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 50/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 53/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 70/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — STJ

✓
VALUE Pass
60/100
STJ trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
55/100
STJ: +0.2%/yr revenue is, +7.5%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✓
PAST Pass
100/100
STJ: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
50/100
Balance sheet STJ: Debt-to-Equity (D/E) ratio 1.58 (leveraged), Current ratio is 1.32 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
53/100
STJ: Gross margin is 68.5% (-3.6 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 53/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✓
INCOME Pass
70/100
STJ: Net profit margin is 15.9%. healthy (≥15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range84-48.83
Volume14.74M
Avg Volume (30D)3M
Beta (1Y)1.20
Share Statistics
EPS (TTM)3.12
Shares Outstanding$282.2M
IPO Date1989-12-07
Financial Highlights & Ratios
Revenue (TTM)$5.54B
Gross Profit$3.8B
EBITDA$1.41B
Net Income$880M
Operating Income$1.03B
Total Cash$677M
Total Debt$6.39B
Net Debt$5.73B
Total Assets$13.06B
Price / Earnings (P/E)25.9
Analyst Forecast
Company Info
ExchangeNYSE
CurrencyUSD

Price Chart

Track all markets on TradingView
STJ
St. Jude Medical, Inc.  ·  NYSE
Healthcare • Medical - Equipment & Services

People Also View

LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
 RHHBF
RHHBF
Roche Holding AG
$418.50
+1.82%
 RHHBY
RHHBY
Roche Holding AG
$51.02
+0.65%
 AZN
AZN
AstraZeneca PLC
$204.38
+1.06%
 NVSEF
NVSEF
Novartis AG
$156.48
+0.00%
 MRK
MRK
Merck & Co., Inc.
$119.96
-0.16%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message